Ovid Therapeutics
OVID
OVID
47 hedge funds and large institutions have $16.5M invested in Ovid Therapeutics in 2018 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 13 increasing their positions, 16 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
47
Holders Change
-2
Holders Change %
-4.08%
% of All Funds
1.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
13
Reduced
16
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
AC
Armistice Capital
New York
|
+$3.87M |
| 2 |
CI
Cowen Inc
New York
|
+$348K |
| 3 |
JPMorgan Chase & Co
New York
|
+$192K |
| 4 |
Renaissance Technologies
New York
|
+$133K |
| 5 |
Two Sigma Investments
New York
|
+$114K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
GPCM
51
Granite Point Capital Management
Boston,
Massachusetts
| – | -$634K | -111,826 | Closed |
|
52
Ameriprise
Minneapolis,
Minnesota
| – | -$443K | -78,034 | Closed |
|
53
Citadel Advisors
Miami,
Florida
| – | -$82K | -14,537 | Closed |
|
|
SIM
54
Spark Investment Management
New York
| – | -$78K | -13,800 | Closed |
|
55
AllianceBernstein
Nashville,
Tennessee
| – | -$67K | -11,746 | Closed |
|
56
Barclays
London,
United Kingdom
| – | -$28K | -4,938 | Closed |
|
|
CHP
57
Cable Hill Partners
Portland,
Oregon
| – | -$6K | -1,000 | Closed |
|